Log in to save to my catalogue

Cannabis Use in Patients With Inflammatory Bowel Disease Following Legalization of Cannabis in Canad...

Cannabis Use in Patients With Inflammatory Bowel Disease Following Legalization of Cannabis in Canad...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3060746878

Cannabis Use in Patients With Inflammatory Bowel Disease Following Legalization of Cannabis in Canada

About this item

Full title

Cannabis Use in Patients With Inflammatory Bowel Disease Following Legalization of Cannabis in Canada

Publisher

England

Journal title

Crohn's & colitis 360, 2024-04, Vol.6 (2), p.otae031-otae031

Language

English

Formats

Publication information

Publisher

England

More information

Scope and Contents

Contents

Cannabis is used by patients with Crohn's disease (CD) and ulcerative colitis (UC) as an alternative to, or in combination with, conventional therapies to treat symptoms such as abdominal pain, poor sleep, and reduced appetite. The clinical efficacy of cannabis for these disorders is controversial, with some studies showing harmful outcomes associa...

Alternative Titles

Full title

Cannabis Use in Patients With Inflammatory Bowel Disease Following Legalization of Cannabis in Canada

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3060746878

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3060746878

Other Identifiers

ISSN

2631-827X

E-ISSN

2631-827X

DOI

10.1093/crocol/otae031

How to access this item